Skip to main content
. 2011 Mar 15;76(11):968–975. doi: 10.1212/WNL.0b013e3182104407

Figure 2. Comparing 3 therapeutic study populations with respect to prognostic factors at hospital admission using modified Erasmus GBS Outcome Score (mEGOS).

Figure 2

Points represent the percentages of patients with a specific mEGOS in a therapeutic trial comparing plasma exchange vs IV immunoglobulin (IVIg) (green), a therapeutic trial comparing IVIg/placebo vs IVIg/methylprednisolone (red), and an observational study (black). Smoothed lines represent the distribution of the study population over the total mEGOS.